Literature DB >> 8505677

Elevated neuropeptide Y in the arcuate nucleus of young obese Zucker rats may contribute to the development of their overeating.

B Beck1, A Burlet, R Bazin, J P Nicolas, C Burlet.   

Abstract

Neuropeptide Y (NPY) mediates feeding behavior through a local hypothalamic network formed by the arcuate and paraventricular nuclei (the AP axis). In the hypothalamus, NPY is mainly synthesized in neurons of the arcuate nucleus. These neurons project to the paraventricular nucleus, the site where NPY has the strongest stimulatory effects on food intake of Sprague-Dawley rats. In the adult Zucker fatty rat (a genetic model of obesity with a well-established hyperphagia), NPY concentrations in these nuclei are higher than in its lean counterpart. We measured hypothalamic NPY before the appearance of altered eating behavior, e.g., in very young (16-d-old) lean and obese Zucker pups, and in pups at an age when overeating had begun, e.g., a few days after weaning at 30 d. At 30 d, NPY concentrations were significantly higher in obese than in lean rats in the arcuate nucleus (14.2 +/- 0.7 vs. 11.6 +/- 0.5 pmol/mg protein, P < 0.01). This difference was not observed at 16 d. A 160% increase was noted in the paraventricular nuclei of obese rats between 16 and 30 d of life compared with a 100% increase in the lean rats (P < 0.001). Neuropeptide Y concentration was greater in 30-d-old rats than in 16-d-old rats in other areas involved in the regulation of feeding behavior, such as the dorsomedian nuclei and lateral hypothalamus, but the values did not differ between genotypes. Higher NPY concentration was therefore detected early in young obese rats in the main hypothalamic site of NPY synthesis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8505677     DOI: 10.1093/jn/123.6.1168

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  7 in total

Review 1.  Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.

Authors:  B Beck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

2.  Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus.

Authors:  P B Jensen; N Blume; J D Mikkelsen; P J Larsen; H I Jensen; J J Holst; O D Madsen
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

3.  NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice.

Authors:  Yan-Chuan Shi; Shu Lin; Iris P L Wong; Paul A Baldock; Aygul Aljanova; Ronaldo F Enriquez; Lesley Castillo; Natalie F Mitchell; Ji-Ming Ye; Lei Zhang; Laurence Macia; Ernie Yulyaningsih; Amy D Nguyen; Sabrina J Riepler; Herbert Herzog; Amanda Sainsbury
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

4.  Central nervous system neuropeptide Y signaling via the Y1 receptor partially dissociates feeding behavior from lipoprotein metabolism in lean rats.

Authors:  Jennifer M Rojas; John M Stafford; Sanaz Saadat; Richard L Printz; Annette G Beck-Sickinger; Kevin D Niswender
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-16       Impact factor: 4.310

5.  Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats.

Authors:  R Vettor; N Zarjevski; I Cusin; F Rohner-Jeanrenaud; B Jeanrenaud
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

6.  NPY presynaptic actions are reduced in the hypothalamic mpPVN of obese (fa/fa), but not lean, Zucker rats in vitro.

Authors:  Nina Pronchuk; William F Colmers
Journal:  Br J Pharmacol       Date:  2004-02-16       Impact factor: 8.739

7.  Central nervous system neuropeptide Y regulates mediators of hepatic phospholipid remodeling and very low-density lipoprotein triglyceride secretion via sympathetic innervation.

Authors:  Jennifer M Rojas; Eveline Bruinstroop; Richard L Printz; Aldijana Alijagic-Boers; Ewout Foppen; Maxine K Turney; Leena George; Annette G Beck-Sickinger; Andries Kalsbeek; Kevin D Niswender
Journal:  Mol Metab       Date:  2015-01-16       Impact factor: 7.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.